ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: No Intention Of Retiring, DeVita Says; Bresnick To Head Eppley; Balch Acting Director at Alabama

October 22, 1982

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

Zerhouni Starts Work As NIH Director

May 24, 2002

Mammography Hazard In ACS-NCI Screening Charged

October 17, 1975